Meet Gynecologic Surgeon Nadeem Abu-Rustum
Meet Gynecologic Surgeon Nadeem Abu-Rustum
Nadeem R. Abu-Rustum, MD, FACOG, FACS
Gynecologic Surgeon
Titles
Chief, Gynecology Service; Avon Chair in Gynecologic Oncology Research; Founder’s Chair
Clinical Expertise
Gynecologic Oncology; Cancers and Tumors of the Cervix, Uterus, Ovary, Vulva, and Vagina; Laparoscopic Surgery; Fertility-Sparing Surgery (Radical Trachelectomy); Prophylactic Laparoscopic Oophorectomy for High-Risk Patients
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Abu-Rustum accepts the following list of insurance providers. Select your insurance provider to see more details.
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO, DSN
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO EPO
Payor Type: Commercial
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): Federal Government
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP
Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): TBD
Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO
Payor Type: Commercial
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Contact and Location
- 212-639-7051 Office Phone
- Follow Dr. Aburustum on Twitter
- Speaks English and Arabic

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
See all locationsAbout Me
Education
MD, American University of Beirut
Residencies
Obstetrics and Gynecology - Greater Baltimore Medical Center
Fellowships
Gynecologic Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
Obstetrics and Gynecology; Gynecologic Oncology
I am a board-certified gynecologic oncologist who specializes in the surgical treatment of gynecologic cancers at Memorial Sloan Kettering Cancer Center.
Read more
As Chief of MSK’s Gynecologic Service, I lead a team of surgeons that performs close to 3,000 gynecologic procedures each year, providing surgical intervention for approximately 600 new cases of endometrial cancer and 500 new cases of ovarian tubal peritoneal cancer, 100 cases of cervical cancer, and 75 cases of vulva cancer annually. Our group of surgeons is highly collaborative in nature and meets weekly to discuss care strategies for all complex and challenging gynecologic cancer cases at MSK. We draw upon the expertise of our disease management team at large to provide the care that will get our patients the best possible outcomes. In addition to my role as Chief of our Gynecologic Service, I am a professor of obstetrics and gynecology at Weill Cornell Medical College.
I have a special interest in minimally invasive surgery (laparoscopy) for the treatment of cancerous and noncancerous diseases of the female reproductive system. My clinical expertise includes minimally invasive and advanced gynecologic surgery for cancers of the ovary, uterus, vulva, and cervix. For selected women who are at an increased risk for ovarian cancer — such as those with a strong family history of breast and ovarian cancer, Lynch syndrome, or mutations in the BRCA1 or BRCA2 genes — we offer laparoscopic prophylactic surgery, if desired, to reduce their risk for disease development.
I also have extensive experience in treating endometrial and cervical cancer. Over the past 20 years, I have pioneered many of the surgical approaches that we use to treat stage 1 cervical cancer, such as radical trachelectomy — a procedure that can preserve fertility in select patients with early-stage cervical cancer. Additionally, I led the effort to investigate and utilize sentinel lymph node mapping — a novel approach for cervical and uterine cancer management that is now being adopted by many oncology practices nationally and internationally. This procedure may improve the detection of cancer that has spread to lymph nodes and limit the side effects of radical surgery.
My clinical research focuses on surgical therapy for gynecologic cancers and innovative surgical approaches to treating gynecologic disorders, such as sentinel node mapping, improved localization of tumors, and fertility-sparing surgery. I am actively involved in the development and improvement of surgical techniques and oversee our surgical research programs. It is my responsibility to ensure that quality surgical care and patient safety are maintained for all gynecologic patients at our institution. Providing this level of service is the utmost priority in my own practice.
I have served as a member of the Gynecologic Oncology Group’s Cervix Committee and the American College of Surgeons’ Committee on Emerging Surgical Technology and Education, and I chair the National Comprehensive Cancer Network’s Uterine Neoplasms, Cervical Cancer, and Vulvar Cancer Committees.
I spend two full days in the operating room each week. I also see patients in the clinic twice a week at MSK’s Rockefeller Outpatient Pavilion on East 53rd Street (between Lexington and Third Avenues) in Manhattan.
When I am not caring for patients with gynecologic cancers, I enjoy traveling, carpentry, astronomy, and spending time with family.
Awards and Honors
- Castle Connolly: America's Top Doctors (2023)
- International Gynecologic Cancer Society IGCS Excellence in Teaching Award (2021)
- Castle Connolly: New York Magazine Top Doctors (2002, 2005-2020)
- Austria AGO Wertheim Award (2019)
- Society of Gynecologic Oncology SGO Innovation Award (2017)
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Co-Investigated by Dr. Abu-Rustum
- Choosing Ovarian Preservation or Removal before Surgery for Endometrial Cancer

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Gynecologic Tumor Board. Dizon Don, Abu-Rustum NR. Sudbury, MA: Jones and Bartlett; 2008.
100 Questions and Answers about Ovarian Cancer. 2nd ed. Dizon Don, Abu-Rustum NR. Sudbury, MA: Jones and Bartlett Publishers; 2006.
Read more
“Innovative 21st century therapies.” Rowinsky EK, Mundt AJ, Abu-Rustum NR. In: Principles and Practice of Gynecologic Oncology. 5th ed. Barakat RR, Markman M, Randall ME, eds. Philadelphia: Lippincott Williams & Wilkins; 2009.
“Schauta radical vaginal hysterectomy and laparoscopic radical hysterectomy.” Sonoda Y, Abu-Rustum NR. In: Operative Gynecologic Laparoscopy and Hysteroscopy. 3rd ed. Nezhat C, Nezhat F, Nezhat C, eds. New York: Cambridge UP; 2008.
“Port site metastasis and pneumoperitoneum.” Are C, Abu-Rustum N. In: Operative Gynecologic Laparoscopy and Hysteroscopy. 3rd ed. New York: Cambridge UP; 2008.
“Cancer of the cervix.” Chi DS, Abu-Rustum NR, Plante M, Roy M. In: TeLinde’s Operative Gynecology. 10th ed. Rock JA, Jones HW, eds. Philadelphia: Lippincott Williams and Wilkins; 2008: 1227.
“Cervical cancer.” Abu-Rustum NR. In: Surgical Oncology: An Algorithmic Approach. Saclarides TJ, Millikan KW, Godellas CV, eds. New York: Springer-Verlag; 2003: 502-513.
DVDs
Easy Learning Hysterectomy. Cibula D, Querleu D, Morrow P, Tamussino K, Bader A, Leblanc E, Benedetti-Panici P, Andou M, Abu-Rustum N. European Prague: Society of Gynaecological Oncology; 2010.
Visit PubMed for a full listing of Dr. Abu-Rustum’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Nadeem R. Abu-Rustum discloses the following relationships and financial interests:
-
Elucida Oncology
Intellectual Property Rights -
Grail
Provision of Services (uncompensated) -
Kliniken Essen-Mitte
Provision of Services
-
National Comprehensive Cancer Network
Provision of Services -
University of Balamand
Fiduciary Role/Position
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].